MDGA1 and acute myeloid leukemia: The discovery of MDGA1 as a potential novel biomarker for inflammation, and in particular for GvHD in AML patients after alloHSCT was only possible due profiling of significantly larger numbers of cells and samples without introducing additional technical batch effects.